BE503994A - - Google Patents
Info
- Publication number
- BE503994A BE503994A BE503994DA BE503994A BE 503994 A BE503994 A BE 503994A BE 503994D A BE503994D A BE 503994DA BE 503994 A BE503994 A BE 503994A
- Authority
- BE
- Belgium
- Prior art keywords
- substances
- solutions
- agglutinate
- tendency
- solution
- Prior art date
Links
- 239000000126 substance Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 102000001399 Kallikrein Human genes 0.000 claims description 3
- 108060005987 Kallikrein Proteins 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 239000002274 desiccant Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 239000003708 ampul Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000013354 porous framework Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940090568 combinations of vitamin Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE503994A true BE503994A (enrdf_load_stackoverflow) |
Family
ID=144989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE503994D BE503994A (enrdf_load_stackoverflow) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE503994A (enrdf_load_stackoverflow) |
-
0
- BE BE503994D patent/BE503994A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69019817T2 (de) | Trägermaterial zur Arzneimittelverabreichung. | |
FI111333B (fi) | Kiinteä kylmäkuivattu annosmuoto ja sen valmistus | |
EP0233853B1 (fr) | Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation | |
CH633445A5 (fr) | Procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic. | |
FR2853547A1 (fr) | Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production | |
BE1007686A4 (fr) | Nouvelles compositions pharmaceutiques a base de sels de calcium. | |
EP0336817A1 (fr) | Particules d'émulsion gélifiées et compositions les contenant | |
EP1352645A1 (en) | Effervescent compositions containing dried fruit juices | |
EP0482345A1 (fr) | Composition nutritionnelle et procédé de préparation | |
JP2000502990A (ja) | 可溶化方法 | |
FR2703249A1 (fr) | Composition pharmaceutique ayant une activité analgésique contenant du naproxène. | |
BE503994A (enrdf_load_stackoverflow) | ||
EP0748339B1 (en) | The manufacture of and uses for low molecular weight agars and agaroids | |
CN116832147B (zh) | Glp1多肽药物冻干闪释片及其制备方法 | |
CA2048471C (en) | Water-containing liposome system | |
CN101450205A (zh) | 一种猪用融合蛋白制剂 | |
CN1208381C (zh) | 以壳聚糖为基质的快速崩解的粒锭 | |
CN102743351A (zh) | 泮托拉唑钠冻干药物组合物 | |
CN101703466A (zh) | 冰片注射剂及其制剂方法 | |
FR2753097A1 (fr) | Gel aqueux ou hydroalcoolique extemporane a viscosite controlee | |
RU2017435C1 (ru) | Способ получения водного раствора меда | |
EP0116182B2 (fr) | Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé | |
BE1007926A3 (fr) | Composition pharmaceutique contenant de la n-acetyl-cysteine. | |
KR940002939B1 (ko) | 고형 엘릭실제(Elixira) 및 그 제조방법 | |
FR3049865B1 (fr) | Composition liquide sublinguale a base d'extrait sec de plante et son procede de preparation. |